, a bio/informatics shared resource is still "open for business" - Visit the CDS website

  1. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells. Shiou SR, Singh AB, Moorthy K, Datta PK, Washington MK, Beauchamp RD, Dhawan P (2007) Cancer Res 67(4): 1571-9
    › Citation · 17308096 (PubMed) · PMC6574217 (PubMed Central)
  2. Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia. Johnson JC, Schmidt CR, Shrubsole MJ, Billheimer DD, Joshi PR, Morrow JD, Heslin MJ, Washington MK, Ness RM, Zheng W, Schwartz DA, Coffey RJ, Beauchamp RD, Merchant NB (2006) Clin Gastroenterol Hepatol 4(11): 1358-65
    › Primary publication · 16996805 (PubMed)
  3. Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta. Shiou SR, Datta PK, Dhawan P, Law BK, Yingling JM, Dixon DA, Beauchamp RD (2006) J Biol Chem 281(45): 33971-81
    › Primary publication · 16959768 (PubMed)
  4. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. Halder SK, Anumanthan G, Maddula R, Mann J, Chytil A, Gonzalez AL, Washington MK, Moses HL, Beauchamp RD, Datta PK (2006) Cancer Res 66(12): 6156-66
    › Citation · 16778189 (PubMed)
  5. Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer. Chakravarthy AB, Kelley MC, McLaren B, Truica CI, Billheimer D, Mayer IA, Grau AM, Johnson DH, Simpson JF, Beauchamp RD, Jones C, Pietenpol JA (2006) Clin Cancer Res 12(5): 1570-6
    › Citation · 16533783 (PubMed)
  6. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis. Halder SK, Beauchamp RD, Datta PK (2005) Exp Cell Res 307(1): 231-46
    › Citation · 15922743 (PubMed)
  7. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK, Beauchamp RD (2005) J Clin Invest 115(7): 1765-76
    › Primary publication · 15965503 (PubMed) · PMC1150288 (PubMed Central)
  8. Cell proliferation: a matter of time and place. Deane NG, Parker MA, Beauchamp RD (2005) Surgery 138(1): 1-7
    › Citation · 16003308 (PubMed)
  9. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Halder SK, Beauchamp RD, Datta PK (2005) Neoplasia 7(5): 509-21
    › Citation · 15967103 (PubMed) · PMC1501161 (PubMed Central)
  10. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells. Mithani SK, Balch GC, Shiou SR, Whitehead RH, Datta PK, Beauchamp RD (2004) J Surg Res 117(2): 296-305
    › Primary publication · 15047135 (PubMed)